首页> 外国专利> Method of submembranous, cytosolic, epigenetic modulation of fertilized mammalian eggs

Method of submembranous, cytosolic, epigenetic modulation of fertilized mammalian eggs

机译:受精哺乳动物卵的亚膜下,胞质表观遗传调控方法

摘要

The subject of the notification is the submembrane, docytozole, epigenetic modulation of in vitro fertilised mammalian ova, which consists of: a sample of non-selective DNA methyl inhibitor (DNMTi) or non-selective nuclear chromatin histone deacetylase inhibitor (HDACi) or a mixture of non-selective DNA methyl inhibitor (DNMTi) and non-selective nuclear chromatin histone deacetylase inhibitor (HDACi) in volume 1:1 a stabiliser buffer,and then a sample of such a buffered solution of a non-selective DNA methyl inhibitor (DNMTi) or a buffered solution of a non-selective nuclear chromatin histone deacetylase inhibitor (HDACi) or a buffered mixture of non-selective DNA methyl inhibitor (DNMTi) and non-selective nuclear chromatin histone deacetylase inhibitor (HDACi) is secured by cryo-preservation,before joining the subcutaneous, docytozole epigenetic modulation of in vitro fertilised ova with a frozen sample of a buffered solution of a non-selective DNA methyl inhibitor (DNMTi) or a buffered solution of a non-selective nuclear chromate histone deacetylase inhibitor (HDACi) or a buffered mixture of non-specific DNA methyl inhibitor (DNMTi) and a non-specific nuclear chromatin histone deacetylase inhibitor (HDACi) is thawed,then the sample is added to the microinjection buffer, supplemented with polyvinylpyrrolidone (PVP) and deposited in a glass micropipette or injection microneedle, and the in vitro fertilised egg cells are subjected to post-acytozole epigenetic transformation by microinjection into the surrounding area, on the one hand over the plasma screen,or plasma,and, on the other hand, under a clear cover,buffered solution of non-specific DNA methyl inhibitor (DNMTi) or buffered solution of non-specific nuclear chromatin histone deacetylase inhibitor (HDACi) or buffered mixture of non-specific DNA methyl inhibitor (DNMTi) and non-specific nuclear chromatin histone deacetylase inhibitor (HDACi).
机译:通知的主题是体外受精哺乳动物卵的亚膜,多细胞唑,表观遗传调控,包括:非选择性DNA甲基抑制剂(DNMTi)或非选择性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)或非选择性DNA甲基抑制剂(DNMTi)和非选择性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)的混合物以稳定剂缓冲液1:1的比例混合,然后是这种非选择性DNA甲基抑制剂的缓冲溶液的样品( DNMTi)或非选择性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)的缓冲溶液或非选择性DNA甲基抑制剂(DNMTi)和非选择性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)的缓冲混合物在加入非选择性DNA甲基抑制剂(DNMTi)缓冲溶液的冷冻样品的冷冻样品后,进行体外受精卵的皮下多扎唑表观遗传调控将非选择性核铬酸盐组蛋白脱乙酰基酶抑制剂(HDACi)或非特异性DNA甲基抑制剂(DNMTi)和非特异性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)的缓冲溶液解冻,然后添加样品补充有聚乙烯吡咯烷酮(PVP)的微量注射缓冲液并沉积在玻璃微量移液管或注射微针中,然后通过显微注射向周围区域对体外受精的卵细胞进行脱细胞唑后表观遗传转化,一方面是通过血浆筛选或血浆,另一方面,在无遮盖的情况下,使用非特异性DNA甲基抑制剂(DNMTi)的缓冲溶液或非特异性核染色质组蛋白脱乙酰酶抑制剂(HDACi)的缓冲溶液或非特异性DNA甲基抑制剂(DNMTi)和非特异性核染色质组蛋白脱乙酰基酶抑制剂(HDACi)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号